MedPath

Comparison of the Incidence of Episiotomy Site Infection With and Without Use of Prophylactic Antibiotics

Phase 3
Conditions
episiotomy site infection.
Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
Registration Number
IRCT20190129042545N1
Lead Sponsor
Bojnourd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
140
Inclusion Criteria

16 to 35 years old
mediolateral episiotomy
mother without underlying disease
no history of chemo therapy
no allergy to antibiotics
not using immunosuppressive or antibiotic medicine
not using alcohol or tobacco
absence of symptomatic vaginitis or lesion or skin allergy in preinea

Exclusion Criteria

Prolonged rupture of membrane (more than 18 hour).
Vaginal delivery with tools.
Third- and fourth-degree perineal tearing

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percent of Episiotomy site infection with usage of prophilactic antibiotics. Timepoint: 7 days after vaginal delivery. Method of measurement: obzervation of episiotomy site by examiner.;Percent of Episiotomy site infection without usage of prophilactic antibiotics. Timepoint: 7 days after vaginal delivery. Method of measurement: obzervation of episiotomy site by examiner.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath